Workflow
Silence Therapeutics PLC(SLN)
icon
Search documents
Silence Therapeutics PLC(SLN) - 2020 Q2 - Earnings Call Transcript
2020-09-14 16:58
Silence Therapeutics Plc (OTC:SLNCF) Q2 2020 Results Conference Call September 14, 2020 8:00 AM ET Company Participants Gem Hopkins - Head, IR and Corporate Communications Iain Ross - Chairman Mark Rothera - President & CEO Giles Campion - Head of R&D and Chief Medical Officer Rob Quinn - Chief Financial Officer Conference Call Participants Patrick Trucchio - H.C. Wainwright Jens Lindqvist - Investec Miles Dixon - Peel Hunt Gem Hopkins Good morning and good afternoon, and thank you for joining us for the Si ...
Silence Therapeutics PLC(SLN) - 2020 Q2 - Earnings Call Presentation
2020-09-14 10:31
Silence Therapeutics H1 2020 Results September 14, 2020 Forward Looking Statements The information contained in this presentation is being supplied and communicated to you solely for your information and may not be reproduced, further distributed to any other person or published, in whole or in part, for any purpose. The distribution of this presentation in certain jurisdictions may be restricted by law, and persons into whose possession this presentation comes should inform themselves about, and observe, a ...
Silence Therapeutics PLC(SLN) - 2019 Q4 - Earnings Call Transcript
2020-04-14 18:36
Silence Therapeutics plc (OTC:SLNCF) Q4 2019 Earnings Conference Call April 14, 2020 8:00 AM ET Company Participants Iain Ross – Interim Executive Chairman Rob Quinn – Chief Financial Officer Giles Campion – Head-R&D and Chief Medical Officer Conference Call Participants Miles Dixon – Peel Hunt Nathaniel Calloway – Edison Group Jens Lindqvist – Investec Iain Ross Hi, good afternoon, everybody. IÂ'm very pleased to be able to present the 2019 results for Silence Therapeutics. I think this is quite an extraor ...
Silence Therapeutics PLC(SLN) - 2018 Q4 - Earnings Call Transcript
2019-03-11 16:25
Silence Therapeutics PLC (OTC:SLNCF) Q4 2018 Earnings Conference Call March 11, 2019 8:00 AM ET Company Participants Dr. David Horn Solomon - President and CEO Rob Quinn - Interim CFO Conference Call Participants Miles Dixon - Peel Hunt LLP Operator Ladies and gentlemen, thank you for standing by. Welcome to the Full Year Results for the Year Ended 31st December 2018. At this time, all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session [Operator In ...
Silence Therapeutics PLC(SLN) - 2018 Q4 - Earnings Call Presentation
2019-03-11 13:26
Full Year Results 2018 Presentation 11 March 2019 Disclaimer (US) The information contained in this presentation is being supplied and communicated to you on a confidential basis solely for your information and may not be reproduced, further distributed to any other person or published, in whole or in part, for any purpose. The distribution of this presentation in certain jurisdictions may be restricted by law, and persons into whose possession this presentation comes should inform themselves about, and obs ...